- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medigen Vaccine Biologics (6547)
Medigen Vaccine Biologics stock price live, this page displays TWO 6547 stock exchange data. View the 6547 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medigen Vaccine Biologics real time stock price chart below.
What Is the Medigen Vaccine Biologics Stock Price Today?
The Medigen Vaccine Biologics stock price today is 42.00.
What Is the Stock Symbol for Medigen Vaccine Biologics?
The stock symbol for Medigen Vaccine Biologics is ""6547.""
What Stock Exchange Does Medigen Vaccine Biologics Trade On?
Medigen Vaccine Biologics is listed and trades on the TPEX stock exchange.
Is Medigen Vaccine Biologics a Good Stock to Buy?
Determining whether Medigen Vaccine Biologics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6547 quote. (ISIN: TW0006547003)
What Is the Medigen Vaccine Biologics Stock Price Today?
The Medigen Vaccine Biologics stock price today is 42.00.
What Is the Stock Symbol for Medigen Vaccine Biologics?
The stock symbol for Medigen Vaccine Biologics is ""6547.""
What Stock Exchange Does Medigen Vaccine Biologics Trade On?
Medigen Vaccine Biologics is listed and trades on the TPEX stock exchange.
Is Medigen Vaccine Biologics a Good Stock to Buy?
Determining whether Medigen Vaccine Biologics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6547 quote. (ISIN: TW0006547003)
TPEX
Currency in TWD
42.00
+1.30(+3.19%)
Closed·
Fair Value
An estimate of a Medigen Vaccine Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.50
42.45
52 wk Range
33.50
56.60
6547 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Medigen Vaccine Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
40.5042.45
52 wk Range
33.5056.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6547 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Medigen Vaccine Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Currently not supported.
Analysts Sentiment
Strong Buy
Price Target
102.00
Upside
+142.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Medigen Vaccine Biologics Company Profile
Medigen Vaccine Biologics Corporation, a biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan. It develops enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection with severe complications; and Quadrivalent influenza vaccine, which is in Phase III clinical trial for the treatment of influenza viruses. The company also develops dengue vaccines, which has completed Phase II clinical trial to treat dengue; anti respiratory syncytial virus (RSV), which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19. Medigen Vaccine Biologics Corporation was incorporated in 2012 and is headquartered in Zhubei City, Taiwan. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp.
Compare 6547 to Peers and Sector
Metrics to compare | 6547 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6547PeersSector | |
|---|---|---|---|---|
P/E Ratio | −83.4x | −26.0x | −0.6x | |
PEG Ratio | −1.12 | −1.17 | 0.00 | |
Price/Book | 3.8x | 3.7x | 2.6x | |
Price / LTM Sales | 23.2x | 106.0x | 3.3x | |
Upside (Analyst Target) | 142.9% | 0.0% | 38.3% | |
Fair Value Upside | Unlock | −14.4% | 4.5% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 102.00
(+142.86% Upside)
Earnings
Latest Release
Nov 07, 2025
EPS / Forecast
-0.07 / 0.07
Revenue / Forecast
205.86M / 184.00M
FAQ
What Stock Exchange Does Medigen Vaccine Biologics Trade On?
Medigen Vaccine Biologics is listed and trades on the Taipei Exchange stock exchange.
What Is the Stock Symbol for Medigen Vaccine Biologics?
The stock symbol for Medigen Vaccine Biologics is "6547."
What Is the Medigen Vaccine Biologics Market Cap?
As of today, Medigen Vaccine Biologics market cap is 13.81B.
What Is Medigen Vaccine Biologics's Earnings Per Share (TTM)?
The Medigen Vaccine Biologics EPS (TTM) is -0.50.
When Is the Next Medigen Vaccine Biologics Earnings Date?
Medigen Vaccine Biologics will release its next earnings report on 11 Mar 2026.
How Many Times Has Medigen Vaccine Biologics Stock Split?
Medigen Vaccine Biologics has split 6 times.
How Many Employees Does Medigen Vaccine Biologics Have?
Medigen Vaccine Biologics has 103 employees.
What is the current trading status of Medigen Vaccine Biologics (6547)?
As of 01 Dec 2025, Medigen Vaccine Biologics (6547) is trading at a price of 42.00, with a previous close of 54.10. The stock has fluctuated within a day range of 40.50 to 42.45, while its 52-week range spans from 33.50 to 56.60.
What Is Medigen Vaccine Biologics (6547) Price Target According to Analysts?
The average 12-month price target for Medigen Vaccine Biologics is TWD102, with a high estimate of TWD102 and a low estimate of TWD102. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +142.86% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.